The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

Cited 2 time in webofscience Cited 1 time in scopus
  • Hit : 437
  • Download : 148
DC FieldValueLanguage
dc.contributor.authorShin, Eui-Cheolko
dc.contributor.authorHan, Ji Wonko
dc.contributor.authorKang, Wonseokko
dc.contributor.authorKato, Takanobuko
dc.contributor.authorKim, Seong-Junko
dc.contributor.authorZhong, Jinko
dc.contributor.authorKim, Seungtaekko
dc.contributor.authorPark, Su-Hyungko
dc.contributor.authorSung, Pil Sooko
dc.contributor.authorWatashi, Koichiko
dc.contributor.authorPark, Jun Yongko
dc.contributor.authorWindisch, Marc P.ko
dc.contributor.authorOh, Jong-Wonko
dc.contributor.authorWakita, Takajiko
dc.contributor.authorHan, Kwang-Hyubko
dc.contributor.authorJang, Sung Keyko
dc.date.accessioned2020-05-07T05:20:14Z-
dc.date.available2020-05-07T05:20:14Z-
dc.date.created2020-05-06-
dc.date.created2020-05-06-
dc.date.created2020-05-06-
dc.date.issued2020-03-
dc.identifier.citationVIRUSES-BASEL, v.12, no.3-
dc.identifier.issn1999-4915-
dc.identifier.urihttp://hdl.handle.net/10203/274128-
dc.description.abstractHepatitis C virus (HCV) infects similar to 71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.-
dc.languageEnglish-
dc.publisherMDPI-
dc.titleThe Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses-
dc.typeArticle-
dc.identifier.wosid000525486800043-
dc.identifier.scopusid2-s2.0-85081904468-
dc.type.rimsART-
dc.citation.volume12-
dc.citation.issue3-
dc.citation.publicationnameVIRUSES-BASEL-
dc.identifier.doi10.3390/v12030302-
dc.contributor.localauthorShin, Eui-Cheol-
dc.contributor.localauthorPark, Su-Hyung-
dc.contributor.nonIdAuthorKang, Wonseok-
dc.contributor.nonIdAuthorKato, Takanobu-
dc.contributor.nonIdAuthorKim, Seong-Jun-
dc.contributor.nonIdAuthorZhong, Jin-
dc.contributor.nonIdAuthorKim, Seungtaek-
dc.contributor.nonIdAuthorSung, Pil Soo-
dc.contributor.nonIdAuthorWatashi, Koichi-
dc.contributor.nonIdAuthorPark, Jun Yong-
dc.contributor.nonIdAuthorWindisch, Marc P.-
dc.contributor.nonIdAuthorOh, Jong-Won-
dc.contributor.nonIdAuthorWakita, Takaji-
dc.contributor.nonIdAuthorHan, Kwang-Hyub-
dc.contributor.nonIdAuthorJang, Sung Key-
dc.description.isOpenAccessY-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorhepatitis C virus-
dc.subject.keywordAuthorantivirals-
dc.subject.keywordAuthorvaccine-
dc.subject.keywordAuthorflavivirus-
dc.subject.keywordAuthorliver diseases-
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 2 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0